Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
76,378,254
-
Total 13F shares
-
10,254,522
-
Share change
-
-274,304
-
Total reported value
-
$109,412,494
-
Price per share
-
$10.67
-
Number of holders
-
35
-
Value change
-
-$6,260,833
-
Number of buys
-
21
-
Number of sells
-
13
Institutional Holders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) as of Q2 2021
As of 30 Jun 2021,
Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,254,522 shares.
The largest 10 holders included
FMR LLC, Artal Group S.A., Euclidean Capital LLC, BlackRock Inc., VANGUARD GROUP INC, Monashee Investment Management LLC, Alphabet Inc., Birchview Capital, LP, GEODE CAPITAL MANAGEMENT, LLC, and Casdin Capital, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.